Use of a combination of an amino acid and elemental calcium as neurotransmitters precursors

20230086586 ยท 2023-03-23

    Inventors

    Cpc classification

    International classification

    Abstract

    This invention relates a method of combining an amino acid, with one of an elemental calcium, potassium, sodium, zinc and magnesium ion as an oral supplement for the purpose of passing the amino acid through the blood brain barrier for the delivery of specific amino acids with a higher PH, for enhancing athletic performance, for reducing fat, and/or as an anti-aging agent.

    Claims

    1. A method of administering orally a combined ionic bonded Amino Acid with one or more of an elemental calcium, potassium, sodium, zinc and magnesium ion for the purpose of increasing penetration of the amount of an amino acid through the blood brain barrier to increase neurotransmitter production.

    2. The method of claim 1 wherein the Amino Acid consists of Gamma-aminobutyric acid.

    3. The method of claim 1 wherein the Amino Acid consists of one or more of L-Hydroxy-Tryptophan, L-Dopa, L-Tyrosine, Acetyl-L-Tyrosine, and L-Glutamic Acid.

    4. The method of claim 1 wherein the administered combination can be utilized for enhancing athletic performance, for reducing fat, increasing neurotransmitters and/or as an anti-aging agent.

    Description

    DETAILED DESCRIPTION

    [0006] It will be apparent to those skilled in the art, that is, to those who have a knowledge or experience in this area of technology that many variations are possible for the method of orally administering a combination of representative amino acids or N-acetylated amino acids which may act as a neurotransmitter such as:

    Either the N-Acetyl or Free Form Amino Acid of one of the following:

    L-Tryptophan

    L-5-Hydroxy-Tryptophan

    L-Tyrosine

    L-Phenylalanine

    D-Phenylalanine

    [0007] Gamma-aminobutyric acid
    L-Glutamic acid

    L-Dopa

    L-Glutamic Acid

    L-Aspartate

    [0008] In the preferred embodiment the amino acid would be Gamma-aminobutyric acid:

    ##STR00001##

    [0009] All of the compound formulations disclosed herein would be administered orally. Alternatively, the formulations might be administered via IV, or sublingually. In the preferred embodiment a selected amino acid would be ionic bonded with an elemental calcium ion in a liquid or solid carrier. In an alternative embodiment the selected amino acid would be bonded with one of a potassium, sodium, zinc and/or magnesium ion. In the preferred embodiment these various compounds would preferably be administered orally mixed with a liquid carrier in appropriate unit doses.

    [0010] The preferred amount of each of the active amino acid and one of an elemental calcium, potassium, sodium, zinc and magnesium ion ingredients within the formulation that is to be orally administered would depend on various factors such as the specific drug or dietary supplement molecular weight that needs to be utilized to obtain the desired result. The concentration of the amino acid compound in the formulation might be between 80% and 90%. It might be between 70% and 80%. The preferred concentration would be 75%. The concentration of the one of an elemental calcium, potassium, sodium, zinc and magnesium ion in the formulation might be between 19% and 20%. It might be between 17% and 22%. The preferred concentration would be 19.5%.

    Example Formulation One

    [0011] 250 mg total weight of elemental magnesium ionic bonded with Gamma-aminobutyric acid in a gelatin capsule for oral administration.

    Example Formulation Two

    [0012] 100 mg total weight of elemental calcium bonded ionically with Gamma-aminobutyric acid in a gelatin capsule for oral administration.

    Example Formulation Three

    [0013] 500 mg total weight elemental magnesium bonded ionically with L-Tryptophan

    [0014] From the foregoing disclosure and detailed description of certain preferred embodiments, it will be apparent that various modifications, additions, and other alternative embodiments are possible without departing from the true scope and spirit of the invention. The embodiments discussed were chosen and described to provide the best illustration of the principles of the invention and its practical application to thereby enable one of ordinary skill in the art to use the invention in various embodiments and with various modifications as are suited to the particular use contemplated. All such modifications and variations are within the scope of the invention as determined by the appended claims when interpreted in accordance with the breadth to which they are fairly, legally, and equitably entitled.